相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons?
Semi B. Harrabi et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults
Tanja Eichkorn et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Brain Necrosis in Adult Patients After Proton Therapy: Is There Evidence for Dependency on Linear Energy Transfer?
Andrzej Niemierko et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
How can scanned proton beam treatment planning for low-grade glioma cope with increased distal RBE and locally increased radiosensitivity for late MR-detected brain lesions?
Julia Bauer et al.
MEDICAL PHYSICS (2021)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
Martin J. van den Bent et al.
LANCET ONCOLOGY (2021)
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression
Norbert Galldiks et al.
NEURO-ONCOLOGY (2020)
Pseudoprogression after radiation therapies for low grade glioma in children and adults: A systematic review and meta-analysis
Victor M. Lu et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma
Ai Muroi et al.
CHILDS NERVOUS SYSTEM (2020)
Late Contrast Enhancing Brain Lesions in Proton-Treated Patients With Low-Grade Glioma: Clinical Evidence for Increased Periventricular Sensitivity and Variable RBE
Emanuel Bahn et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma
Daniel J. Indelicato et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
Hongqing Zhuang et al.
MOLECULAR CANCER (2019)
Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy
Ethan B. Ludmir et al.
NEURO-ONCOLOGY (2019)
Predicting late magnetic resonance image changes in glioma patients after proton therapy
J. Eulitz et al.
ACTA ONCOLOGICA (2019)
Imaging Glioblastoma Posttreatment Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis
Sara B. Strauss et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2019)
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide
Michael Dworkin et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy
Beat Bojaxhiu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial
Yongteng Xu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation
Allison M. Martin et al.
JAMA ONCOLOGY (2018)
Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
Balamurugan Vellayappan et al.
FRONTIERS IN ONCOLOGY (2018)
Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
Anastasia Zikou et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2018)
The 2016 World Health Organization classification of tumours of the central nervous system
Chiara Villa et al.
PRESSE MEDICALE (2018)
Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology
Jay S. Detsky et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Martin J. van den Bent et al.
LANCET (2017)
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
Michael Weller et al.
LANCET ONCOLOGY (2017)
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
Sied Kebir et al.
CLINICAL CANCER RESEARCH (2016)
Exponential Increase in Relative Biological Effectiveness Along Distal Edge of a Proton Bragg Peak as Measured by Deoxyribonucleic Acid Double-Strand Breaks
John J. Cuaron et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2016)
Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma
S. B. M. D. Harrabi et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2016)
Radiation Necrosis in Pediatric Patients with Brain Tumors Treated with Proton Radiotherapy
S. F. Kralik et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
Zachary A. Kohutek et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
An analysis of radiation necrosis of the central nervous system treated with bevacizumab
Karen Tye et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Comparison of 11C-Methionine, 11C-Choline, and 18F-Fluorodeoxyglucose-Positron Emission Tomography for Distinguishing Glioma Recurrence from Radiation Necrosis
Shunsuke Takenaka et al.
NEUROLOGIA MEDICO-CHIRURGICA (2014)
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
T. Nihashi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT
Sellam Karunanithi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Radiation-induced blood-brain barrier damages: An in vitro study
William Fauquette et al.
BRAIN RESEARCH (2012)
Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
Edward G. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF BEVACIZUMAB THERAPY FOR RADIATION NECROSIS OF THE CENTRAL NERVOUS SYSTEM
Victor A. Levin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
Giuseppe Minniti et al.
RADIATION ONCOLOGY (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pseudoprogression and pseudoresponse in the treatment of gliomas
Dieta Brandsma et al.
CURRENT OPINION IN NEUROLOGY (2009)
CNS complications of radiotherapy and chemotherapy
Carole Soussain et al.
LANCET (2009)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy
Yuzo Terakawa et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
Molecular targets in radiation-induced blood-brain barrier disruption
RA Nordal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
分享论文
